Compare INM & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INM | NDRA |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8M | 7.4M |
| IPO Year | 2020 | 2016 |
| Metric | INM | NDRA |
|---|---|---|
| Price | $15.56 | $4.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 67.2K | 8.9K |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.68 | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,942,633.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $2.96 |
| 52 Week High | $16.44 | $6.95 |
| Indicator | INM | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 99.25 | 43.78 |
| Support Level | $1.00 | $4.74 |
| Resistance Level | N/A | $5.24 |
| Average True Range (ATR) | 0.50 | 0.31 |
| MACD | 1.26 | 0.02 |
| Stochastic Oscillator | 86.67 | 64.88 |
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.